Standout Papers

Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's Dise... 2001 2026 2009 2017 1.1k
  1. Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's Disease (2001)
    Christine M. Eng, Nathalie Guffon et al. New England Journal of Medicine
  2. Elevated globotriaosylsphingosine is a hallmark of Fabry disease (2008)
    Johannes M. F. G. Aerts, J.E.M. Groener et al. Proceedings of the National Academy of Sciences
  3. Rhabdomyolysis: Review of the literature (2014)
    Rodi Zutt, Anneke J. van der Kooi et al. Neuromuscular Disorders

Immediate Impact

2 by Nobel laureates 12 from Science/Nature 71 standout
Sub-graph 1 of 19

Citing Papers

Direct radical functionalization of native sugars
2024 StandoutNature
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia
2024 StandoutNature
2 intermediate papers

Works of Gabor E. Linthorst being referenced

Elevated globotriaosylsphingosine is a hallmark of Fabry disease
2008 Standout
Long-Term Safety and Efficacy of Enzyme Replacement Therapyfor Fabry Disease
2004

Author Peers

Author Last Decade Papers Cites
Gabor E. Linthorst 5454 2756 1615 89 6.9k
Dominique P. Germain 7347 3520 2137 214 9.5k
Nathalie Guffon 5025 2323 1031 136 6.3k
Stephen Waldek 3744 1767 1087 56 4.3k
Paige Kaplan 2826 1485 849 135 5.6k
Christine M. Eng 2622 1278 619 81 5.5k
Uma Ramaswami 2863 1368 714 113 3.8k
Emil Kakkis 3381 1645 598 73 4.8k
Rossella Parini 3026 1228 726 175 4.9k
Markus Ries 3219 1484 895 100 3.9k
Pramod K. Mistry 4754 2120 1588 169 6.6k

All Works

Loading papers...

Rankless by CCL
2026